United Advisor Group’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$697K Hold
17,600
– – 0.07% 279
2026
Q2
$596K Hold
17,600
– – 0.06% 286
2026
Q1
$530K Hold
17,600
– – 0.07% 273
2025
Q4
$549K Buy
17,600
+1,500
+9% +$37K 0.07% 265
2025
Q3
$325K Buy
+16,100
New +$283K 0.04% 343

Other funds holding TEVA

United Advisor Group's TEVA Position: Q3 2026 in Review

United Advisor Group held its Teva Pharmaceutical Industries (TEVA) position steady in Q3 2026 at 17,600 shares worth $697K. The position accounts for 0.07% of the portfolio, ranked #279.

United Advisor Group first reported a position in TEVA in Q3 2025 and has held it in 5 quarters since. 530 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • United Advisor Group held 17,600 shares of Teva Pharmaceutical Industries worth $697K as of Q3 2026.
  • United Advisor Group left its Teva Pharmaceutical Industries share count unchanged in Q3 2026.
  • Teva Pharmaceutical Industries made up 0.07% of United Advisor Group's portfolio in Q3 2026, its #279 holding.
  • United Advisor Group first reported a position in Teva Pharmaceutical Industries in Q3 2025 and has held it in 5 quarters since.
  • 530 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on United Advisor Group's 13F filing for Q3 2026, filed 3 Nov 2026.